KMB

Kimberly-Clark Corporation

Consumer DefensiveHousehold & Personal ProductsNASDAQ

$97.60

-$1.12 (-1.14%)today

Conviction

0/ 10

Fair Value$113.31

Upside+16.09%

Signal0

Market Cap$31.4B

52W Range$94.37–$144.31

Next EarningsApr 28

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$41.80

Current Price$98.20

Upside / Down-57.4%

P(Undervalued)0.0%

P(20%+ Up)0.0%

P(15%+ Down)100.0%

Fair Value Distribution — percentile bands

0.0% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

14.9%/yr

±5.7% · revenue growth to justify current price

FCF-Based Reverse DCF

12.9%/yr

±3.0% · FCF growth to justify current price

THE GAP

Market pricing margin expansion or capex normalization

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Quick Take

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States.

Trailing P/E19.4x

Forward P/E12.3x

P/S1.9x

EPS (TTM)$4.86

Analyst Target$113.31

Analyst Upside16.1%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10kMar 2

Conviction: unchanged

Kimberly-Clark 2025 10-K: Portfolio Transformation Underway

Kimberly-Clark's 2025 10-K shows transformation in progress. Organic growth of 1.7% is solid but masked by divestitures and FX headwinds. The planned Kenvue acquisition (consumer health) is transforma...